Unlocking Next Generation Therapies
Using microfluidics, automation and machine learning
From regenerating damaged tissues to leveraging the immune system to fight cancer, new waves of therapies are about to break through to patients worldwide. Complex, cell-based assays are the workhorses behind these breakthroughs. We work at the frontier of microfluidics, automation and machine learning to turbocharge these complex-cell based assays, and accelerate the advent of these next generation therapies.